PAVmed Inc Q2 2025 Earnings Call Transcript

The following is excerpted from the question-and-answer section of the transcript.

Question: Anthony Vendetti - Maxim Group LLC - Analyst : Thank you. Good morning. So a couple things on the rollout with OSU, I know it has to be integration with EHRs and used to follow the healthcare information technology industry very closely and having those integrations with different systems within a hospital sometimes takes longer than expected. Where is that specific process was integrating Veris' remote monitoring in with that EHR? And is that what's taking a little bit longer or have you overcome that and then? And then the AI component, just a little more clarity on on that clinical decision support piece of it. It sounds like that's early stage, but could be very interesting going forward to add to the Veris platform.

Question: Anthony Vendetti - Maxim Group LLC - Analyst : Yeah. No, that's great. And then and then just on the on the funding component is very still funded at this point through FDA submission and expected clearance. And then any any additional color around that, that timeline in '26 would would be helpful.

Question: Anthony Vendetti - Maxim Group LLC - Analyst : Okay, excellent. Thanks so much. I'll hop back in the queue.

Question: Edward Woo - Ascendiant Capital Markets LLC - Analyst : Yeah. Congratulations on all the progress. My question is on the biopharma opportunity. Is there a specific area that you have been looking at that you may continue to focus on for the next opportunity that you're evaluating?

Question: Edward Woo - Ascendiant Capital Markets LLC - Analyst : Great. Thanks for answering my questions, and I wish you guys good luck. Thank you.